Cerebral Venous thrombosis, Neutropenia and iron-deficiency Anemia in Huntington Disease

References

• Bates GP , DorseyR, GusellaJFet al. Huntington disease. Nat. Rev. Dis. Prim., 1(1), 15005 (2015).
   PubMedGoogle Scholar
• Sassone J , ColciagoC, CislaghiG, SilaniV, CiammolaA. Huntington’s disease: the current state of research with peripheral tissues. Exp. Neurol., 219(2), 385–397 (2009).
   PubMed Web of Science ®Google Scholar
• Muller M , LeavittBR. Iron dysregulation in Huntington’s disease. J. Neurochem., 130(3), 328–350 (2014).
   PubMed Web of Science ®Google Scholar
• Drouin-Ouellet J , SawiakSJ, CisbaniGet al. Cerebrovascular and blood-brain barrier impairments in Huntington’s disease: potential implications for its pathophysiology. Ann. Neurol., 78(2), 160–177 (2015).
   PubMed Web of Science ®Google Scholar
• Tavakoli M , BarekatainM, EmsakiG. An Iranian normative sample of the color trails test. Psychol. Neurosci., 8(1), 75–81 (2015).
   Google Scholar
• Tavakoli M , BarekatainM, DoustHTN, MolaviH, NouriRK, MoradiAet al. Cognitive impairments in patients with intractable temporal lobe epilepsy. J. Res. Med. Sci., 91(2), 104–112 (2013).
   Google Scholar
• Salehi Fadardi JZS . Implicit cognitive processes and attention bias toward addictive behaviors: introduction, development and application of addiction stroop test. J. Fundam. Ment. Heal., 12(1), 358–389 (2010).
   Google Scholar
• Nili Pour R , ShahbazAP, GhoreishiZS, YousefiA. Measures of reliability and validity of Persian picture naming battery. Speech Language Pathol., 1(4), 18–25 (2014).
   Google Scholar
• Eshaghi A , Riyahi-AlamS, RoostaeiTet al. Validity and reliability of a Persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Clin. Neuropsychol., 26(6), 975–984 (2012).
   PubMed Web of Science ®Google Scholar
• Macerollo A , PerryR, StamelouMet al. Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington’s disease: an epiphenomenon which causes diagnostic difficulty. Eur. J. Neurol., 21(2), 16–17 (2014).
   Web of Science ®Google Scholar
• Ho VB , ChuangHS, RoviraMJ, KooB. Juvenile Huntington disease: CT and MR features. Am. J. Neuroradiol., 16(7), 1405–1412 (1995).
   PubMed Web of Science ®Google Scholar
• Cloud LJ , RosenblattA, MargolisRLet al. Seizures in juvenile Huntington’s disease: frequency and characterization in a multicenter cohort. Mov. Disord., 27(14), 1797–1800 (2012).
   PubMed Web of Science ®Google Scholar
• Capecchi M , AbbattistaM, MartinelliI. Cerebral venous sinus thrombosis. J. Thromb. Haemost., 16(10), 1918–1931 (2018).
   PubMed Web of Science ®Google Scholar
• Sipilä JOT , MajamaaK. Epidemiology of stroke in Finnish patients with Huntington’s disease. Acta Neurol. Scand., 134(1), 61–66 (2016).
   PubMed Web of Science ®Google Scholar
• Lin CY , HsuYH, LinMHet al. Neurovascular abnormalities in humans and mice with Huntington’s disease. Exp. Neurol., 250, 20–30 (2013).
   PubMed Web of Science ®Google Scholar
• Montoro-García S , SchindewolfM, StanfordS, LarsenO, ThieleT. The role of platelets in venous thromboembolism. Semin. Thromb. Hemost., 42(03), 242–251 (2016).
   PubMedGoogle Scholar
• Muramatsu Y , KaiyaH, ImaiH, NozakiM, FujimuraH, NambaM. Abnormal platelet aggregation response in Huntington’s disease. Arch. Psychiatr. Nervenkr., 232(3), 191–200 (1982).
   PubMedGoogle Scholar
• Varani K , AbbracchioMP, CannellaMet al. Aberrant A2A receptor function in peripheral blood cells in Huntington’s disease. FASEB J., 17(14), 2148–2150 (2003).
   PubMedGoogle Scholar
• Espinosa-Parrilla Y , Gonzalez-BillaultC, FuentesE, PalomoI, AlarcónM. Decoding the role of platelets and related microRNAs in aging and neurodegenerative disorders. Front. Aging Neurosci., 11, 151 (2019).
   PubMed Web of Science ®Google Scholar
• Denis HL , Lamontagne-ProulxJ, St-AmourIet al. Platelet abnormalities in Huntington’s disease. J. Neurol. Neurosurg. Psychiatry, 90(3), 272–283 (2019).
   PubMed Web of Science ®Google Scholar
• Carrizzo A , DiPardo A, MaglioneVet al. Nitric oxide dysregulation in platelets from patients with advanced Huntington disease. PLoS ONE, 9(2), 2–7 (2014).
   Web of Science ®Google Scholar
• Loscalzo J . Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res., 88(8), 756–762 (2001).
   PubMed Web of Science ®Google Scholar
• Chen CM , WuYR, ChengMLet al. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients. Biochem. Biophys. Res. Commun., 359(2), 335–340 (2007).
   PubMed Web of Science ®Google Scholar
• Bartzokis GTT . MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer’s and Huntingon’s disease. Cell. Mol. Biol., 46(4), 821–833 (2000).
   PubMed Web of Science ®Google Scholar
• Bartzokis G , LuPH, TishlerTAet al. Myelin breakdown and iron changes in Huntington’s disease: pathogenesis and treatment implications. Neurochem. Res., 32(10), 1655–1664 (2007).
   PubMed Web of Science ®Google Scholar
• Dexter DT , CarayonA, Javoy-agidFet al. Alterations in the levels of iron, ferritin and other trace metals in parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain, 114(4), 1953–1975 (1991).
   PubMedGoogle Scholar
• Rosas HD , ChenYI, DorosGet al. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch. Neurol., 69(7), 887–893 (2012).
   PubMedGoogle Scholar
• Chen J , MarksE, LaiBet al. Iron accumulates in Huntington’s disease neurons: protection by deferoxamine. PLoS ONE, 8(10), 1–12 (2013).
   Web of Science ®Google Scholar
• Urrutia PJ , MenaNP, NúñezMT. The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front. Pharmacol., 5, 38 (2014).
   PubMed Web of Science ®Google Scholar
• Bonilla E , EstévezJ, SuárezHet al. Serum ferritin deficiency in Huntington’s disease patients. Neurosci. Lett., 129(1), 22–24 (1991).
   PubMed Web of Science ®Google Scholar
• Morrison PJ , NevinNC. Serum iron total iron binding capacity and ferritin in early Huntington disease patients. Ir. J. Med. Sci., 163(5), 236–237 (1994).
   PubMed Web of Science ®Google Scholar
• Stolz E , ValduezaJM, GrebeMet al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited: results of a prospective study. J. Neurol., 254(6), 729–734 (2007).
   PubMed Web of Science ®Google Scholar
• Silvis SM , ReinstraE, HiltunenSet al. Anaemia at admission is associated with poor clinical outcome in cerebral venous thrombosis. Eur. J. Neurol., 27(4), 716–722 (2020).
   PubMed Web of Science ®Google Scholar
• Kaiafa G , SavopoulosC, KanellosIet al. Anemia and stroke: where do we stand? Acta Neurol. Scand., 135(6), 596–602 (2017).
   PubMed Web of Science ®Google Scholar
• Ho KM , YipCB, DuffO. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J. Thromb. Haemost., 10(9), 1768–1774 (2012).
   PubMed Web of Science ®Google Scholar
• Shiu YT , McIntireLV. In vitro studies of erythrocyte-vascular endothelium interactions. Ann. Biomed. Eng., 31(11), 1299–1313 (2003).
   PubMed Web of Science ®Google Scholar